ClearPoint Neuro (CLPT) Stock Price, Quote, News & History

Comments

ClearPoint Neuro Inc (CLPT) Stock Price, Quote, News & History

CLPTNASDAQ

Trade with Public

$10.79

-0.74-6.42%

At close: Mar 13, 5:00 PM EST

$10.99

0.201.85%

After Hours: 7:59 PM EST

Earnings: Q4 2025 Earnings in 3 days from now on Tue Mar 17th, after the market close

Conference Call: Conference call scheduled in 3 days at 4:30 PM

Click to view the webcast

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$11.65

Close

$10.79

Volume / Avg.

605.26K / 820.16K

Day Range

$10.67 - $11.89

52 Wk Range

8.63 - 30.10

Market Cap

$326.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

11.56%

Days to Cover

5.6

Recent Clearpoint Neuro Inc News

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $28 to $18.

Benzinga Newsdesk

ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software

ClearPoint Neuro receives EU certification for its navigation software, expanding brain surgery access as the company reports strong revenue growth and outlines higher sales expectations for 2026.

Vandana Singh

PRO
ClearPoint Neuro Receives EU MDR Certification For Its ClearPoint Navigation Software Version 3.0.2

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.09M

Investing Cash Flow (TTM)

-736.00K

Financing Cash Flow (TTM)

30.65M

Free Cash Flow (TTM)

-13.82M

Capital Expenditure (TTM)

-736.00K

Net Change in Cash (TTM)

16.83M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$318.21M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.41

PB Ratio (TTM)

21.63

Earnings Yield % (TTM)

-7.19%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.53

Company Debt

Total Debt

$29.20M

LT Debt

$29.20M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$38.22M

Debt to Equity

2.25

Issuance of Debt (TTM)

$28.65M

Repayment of Debt (TTM)

$0

Key Statistics

Open

$11.65

Close

$10.79

Volume / Avg.

605.26K / 820.16K

Day Range

$10.67 - $11.89

52 Wk Range

8.63 - 30.10

Market Cap

$326.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

11.56%

Days to Cover

5.6

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imagi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ClearPoint Neuro (CLPT) stock?

A

You can purchase shares of ClearPoint Neuro (NASDAQ:CLPT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ClearPoint Neuro (CLPT) competitors?

A

Other companies in ClearPoint Neuro’s space includes: CeriBell Inc (NASDAQ:CBLL), NeuroPace Inc (NASDAQ:NPCE), SI-BONE Inc (NASDAQ:SIBN), Sight Sciences Inc (NASDAQ:SGHT) and Varex Imaging Corp (NASDAQ:VREX).

Q

What is the forecast, or price target, for ClearPoint Neuro (CLPT) stock?

A

ClearPoint Neuro has a consensus price target of $24.33.

Q

What is the current price for ClearPoint Neuro (CLPT)?

A

The stock price for ClearPoint Neuro (NASDAQ: CLPT) is $10.99 last updated March 13, 2026 at 7:59 PM EDT.

Q

Does ClearPoint Neuro (CLPT) pay a dividend?

A

There are no upcoming dividends for ClearPoint Neuro.

Q

When is ClearPoint Neuro (NASDAQ:CLPT) reporting earnings?

A

ClearPoint Neuro does not have any upcoming earnings scheduled.

Q

Is ClearPoint Neuro (CLPT) going to split?

A

There is no upcoming split for ClearPoint Neuro.

Q

What sector and industry does ClearPoint Neuro (CLPT) operate in?

A

ClearPoint Neuro is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch

Key Statistics

Open

$11.65

Close

$10.79

Volume / Avg.

605.26K / 820.16K

Day Range

$10.67 - $11.89

52 Wk Range

8.63 - 30.10

Market Cap

$326.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

11.56%

Days to Cover

5.6

Recent Clearpoint Neuro Inc News

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $28 to $18.

Benzinga Newsdesk

ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software

ClearPoint Neuro receives EU certification for its navigation software, expanding brain surgery access as the company reports strong revenue growth and outlines higher sales expectations for 2026.

Vandana Singh

PRO
ClearPoint Neuro Receives EU MDR Certification For Its ClearPoint Navigation Software Version 3.0.2

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.09M

Investing Cash Flow (TTM)

-736.00K

Financing Cash Flow (TTM)

30.65M

Free Cash Flow (TTM)

-13.82M

Capital Expenditure (TTM)

-736.00K

Net Change in Cash (TTM)

16.83M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$318.21M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.41

PB Ratio (TTM)

21.63

Earnings Yield % (TTM)

-7.19%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.53

Company Debt

Total Debt

$29.20M

LT Debt

$29.20M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$38.22M

Debt to Equity

2.25

Issuance of Debt (TTM)

$28.65M

Repayment of Debt (TTM)

$0

Key Statistics

Open

$11.65

Close

$10.79

Volume / Avg.

605.26K / 820.16K

Day Range

$10.67 - $11.89

52 Wk Range

8.63 - 30.10

Market Cap

$326.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

11.56%

Days to Cover

5.6

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imagi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry